A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Serevent Diskus Patient, Information, Instructions - Salmeterol Xinafoate (inhalation powder)
Serevent Diskus Patient, Information, Instructions - Salmeterol Xinafoate (inhalation powder)
PATIENT INFORMATION
It is important that patients understand how to use the DISKUS
inhalation device appropriately and how it should be used in relation
to other asthma medications they are taking. Patients should be
given the following information:
1. The action of SEREVENT
DISKUS may last up to 12 hours or longer. The recommended dosage
(one inhalation twice
daily, morning and evening) should not be exceeded.
2. SEREVENT DISKUS is not meant to relieve
acute asthma
symptoms and extra doses should not be used for that purpose. Acute
symptoms should be treated with an inhaled, short-acting beta2-agonist
such as albuterol (the
physician should provide
the patient with such
medication and instruct
the patient in how it
should be used).
3. When used for the treatment
of EIB, one inhalation
of SEREVENT DISKUS inhalation powder
should be taken 30 minutes before exercise.
- Additional doses of SEREVENT should not be used for 12 hours.
- Patients who are receiving SEREVENT DISKUS inhalation
powder twice daily
should not use additional SEREVENT for prevention
of EIB.
4. The physician
should be notified immediately if any of the following situations
occur, which may be a sign
of seriously worsening asthma:
- Decreasing effectiveness
of inhaled, short-acting beta2-agonists
- Need for more inhalations than usual of inhaled, short-acting
beta2-agonists
- Use of four or more inhalations per
day of a short-acting beta2-agonist for 2 or more days
consecutively
- Use of more than one canister of an inhaled, short-acting beta2-agonist
in an 8-week period
(i.e., canister with 200 inhalations)
5. SEREVENT DISKUS should not be used as a substitute
for oral or inhaled corticosteroids.
The dosage of these medications
should not be changed and they should not be stopped without
consulting the physician,
even if the patient
feels better after initiating treatment with SEREVENT
DISKUS.
6. Patients should be cautioned regarding common adverse cardiovascular
effects, such as
palpitations, chest pain,
rapid heart rate, tremor,
or nervousness.
7. In patients receiving
SEREVENT DISKUS, other inhaled medications should be used only as
directed by the physician.
8. SEREVENT DISKUS should not be used with a spacer.
9. If you are pregnant
or nursing, contact
your physician about
use of SEREVENT DISKUS.
10. Effective and safe use of the DISKUS device
includes an understanding of the way that it should be used:
- Never exhale into the DISKUS device.
- Always activate
and use the DISKUS device
in a level, horizontal
position.
- Never wash the mouthpiece
or any proof of the DISKUS
device. KEEP IT DRY.
top
